VariableBientôt
NovexisCJC-1295
THB 0
Choisir une option
—
OVERVIEW
CJC-1295 without DAC 5mg + IPA 5mg
This peptide combination features CJC-1295 without DAC paired with Ipamorelin to study synergistic growth hormone release pathways and recovery signaling.
Livraison gratuite
Commandes dès ฿500
Retour gratuit
Sous 30 jours
Garantie
100% original
Livraison soignée
Emballage sécurisé
OVERVIEW
This peptide combination features CJC-1295 without DAC paired with Ipamorelin to study synergistic growth hormone release pathways and recovery signaling.
TYPICAL RESEARCH DOSING
Typical research use ranges from 100–300mcg per peptide, administered 1–3 times daily.
PRIMARY RESEARCH APPLICATION
- Growth hormone secretion studies
- Recovery and performance pathway research
- Sleep and recovery investigations
- IGF-1 modulation studies
KEY RESEARCH BENEFITS
- Synergistic stimulation of GH pathways
- Investigated for pulsatile GH release patterns
- Supports recovery and tissue repair research
- Frequently utilized in metabolic and endocrine models